newspaper publishers are always ready to ask authors to disclose individual contributions to documents and potential conflicts of interest. Today, the editors of PLoS Medicin ea published an editorial calling for publishers to do the same thing because their "political and scientific opinions, personal relationships and financial and professional interests can any conceivable interfere with the objectivity of their decisions. "
an example is the additional incentive of publishing documents that may be reprinted as best sellers, when drafting committees have to consider survival magazine in a world increasingly competitive, in addition to scientific merit.
editorial identifies four other issues that contribute to a bias in the medical literature and a lack of transparency in scientific publications, namely, recognition of interests beyond trade, the problem of ghost writing, undisclosed original protocols, and through the publication to only "" exciting results.
Fiona Godlee, editor of British Medical Journal said that "he is a good leader, together pulling the questions that have been well aired before but remain important, and it is excellent that PLoS defends the publication ethics in this way. "For now, the BMJ guidelines for publishing address these concerns," except that this time, we ask the authors, reviewers and editors to report only financial competing interests " Godlee said, "but this policy is under review, and the plan is to extend the obligation of non-financial interests as well in competition. "
Katrina Kelner, deputy editor for life sciences at science , agrees that" publication bias medically relevant results is a serious problem and newspapers can be a place where efforts can be made to ensure that this bias is minimized. " According Kelner Science already follows most of the guidelines presented by PLoS editorial. It also points out that open access is not the only way to avoid conflicts of interest introduced by sales reprint. If editors are strictly separated from management business newspaper publishers should never be aware reprint sales, Kelner says, citing Science 's example.
"The concepts raised by PLoS publishers are important, but not new and have been treated by our organization," said Margaret Winkler, president of the World Association of Medical Editors. Winkler points out another problem that editorial failures, necessary for full transparency in the medical literature, namely the requirement that "the authors register clinical trials in early trial rather than after they determine the results, or results are to their liking. "
0 Komentar